<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04158284</url>
  </required_header>
  <id_info>
    <org_study_id>KRANIOPHARYNGEOM Registry 2019</org_study_id>
    <nct_id>NCT04158284</nct_id>
  </id_info>
  <brief_title>Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts</brief_title>
  <official_title>KRANIOPHARYNGEOM Registry 2019 Multicenter Registry for Patients With Childhood-onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Oldenburg gGmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Deutsche Gesellschaft für Kinderendokrinologie und Diabetologie (DGKED)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Deutsche Gesellschaft für Endokrinologie (DGE)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arbeitsgemeinschaft Pädiatrische Radioonkologie (APRO)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Deutschen Gesellschaft für Radioonkologie (DEGRO)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Klinikum Oldenburg gGmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      KRANIOPHARYNGEOM Registry 2019 will prospectively collect and descriptively analyse data on
      diagnostics, treatment, and follow-up of patients with craniopharyngioma. In continuation of
      preceding studies also patients with xanthogranuloma, meningioma, pituitary adenoma,
      prolactinoma and cystic intracranial malformations will be registered.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>3 years follow-up</time_frame>
    <description>Overall survival as measured by Kaplan Meyer analyses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Progression-free Survival (PFS)</measure>
    <time_frame>3 years follow-up</time_frame>
    <description>Progression-free survival as measured by Kaplan Meyer analyses</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life (QoL)</measure>
    <time_frame>3 years follow-up</time_frame>
    <description>Domains of the PedQol instrument (questionnaire for assessment of health-related QoL in childhood cancer patients.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Craniopharyngioma</condition>
  <condition>Obesity</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Newly diagnosed patients (≤ 18 years of age) with childhood-onset craniopharyngioma
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosed with craniopharyngioma for the first time

          2. Age at diagnosis 18 years or less of age

          3. Agreement from patient's parents or legal guardian as well as the patient

        Exclusion Criteria:

          1. Age at diagnosis over 18 years of age

          2. Diagnosis different from craniopharyngioma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hermann L Mueller, MD</last_name>
    <phone>+49 441 403</phone>
    <phone_ext>2013</phone_ext>
    <email>mueller.hermann@klinikum-oldenburg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Svenja Boekhoff</last_name>
    <phone>+49 441 403</phone>
    <phone_ext>2072</phone_ext>
    <email>boekhoff.svenja@klinikum-oldenburg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinikum Oldenburg</name>
      <address>
        <city>Oldenburg</city>
        <state>Niedersachsen</state>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hermann L Mueller, MD</last_name>
      <phone>+49 441 403</phone>
      <phone_ext>2013</phone_ext>
      <email>mueller.hermann@klinikum-oldenburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Svenja Boekhoff</last_name>
      <phone>+49 441 403</phone>
      <phone_ext>2072</phone_ext>
      <email>boekhoff.svenja@klinikum-oldenburg.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 10, 2019</study_first_submitted>
  <study_first_submitted_qc>November 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2019</study_first_posted>
  <last_update_submitted>November 6, 2019</last_update_submitted>
  <last_update_submitted_qc>November 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum Oldenburg gGmbH</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Hermann Mueller</investigator_full_name>
    <investigator_title>Professor MD</investigator_title>
  </responsible_party>
  <keyword>Quality of life</keyword>
  <keyword>Endocrinology</keyword>
  <keyword>Oncology</keyword>
  <keyword>Hypothalamus</keyword>
  <keyword>Irradiation</keyword>
  <keyword>Neurosurgery</keyword>
  <keyword>Pediatric Brain tumors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Meningioma</mesh_term>
    <mesh_term>Pituitary Neoplasms</mesh_term>
    <mesh_term>Craniopharyngioma</mesh_term>
    <mesh_term>Adamantinoma</mesh_term>
    <mesh_term>Arachnoid Cysts</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

